Search
Mirum Pharmaceuticals Inc
MIRMAdd to Watchlist
123.770USD
0.0000.00%
Close 06/26, 16:00（ET）Quotes delayed by 15 min
7.55BMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
By BusinessUSD
Name
Revenue
Proportion
Livmarli
360.01M
69.06%
Bile Acid Medicines
161.31M
30.94%
License and other revenue
0.00
0.00%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Livmarli
360.01M
69.06%
Bile Acid Medicines
161.31M
30.94%
License and other revenue
0.00
0.00%
